Patent details

Basic Information

Publication number:

EP3250929

PCT Application Number:

GB2016050200

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP167027820

PCT Publication Number:

WO2016120633

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

DIAGNOSIS OF RISK OF UROTHELIAL CANCER

French Title of Invention:

DIAGNOSTIC DE RISQUE DE CANCER UROTHÉLIAL

German Title of Invention:

DIAGNOSE DES RISIKOS AUF UROTHELKREBS

SPC Number:

Dates

Filing date:

29/01/2016

Grant date:

25/03/2020

EP Publication Date:

06/12/2017

PCT Publication Date:

04/08/2016

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

25/03/2020

EP B1 Publication Date:

25/03/2020

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

29/01/2021

Expiration date:

29/01/2036

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

18/03/2020

 

 

Name:

Randox Laboratories Ltd.

Address:

Ardmore 55 Diamond Road Crumlin Co. Antrim BT29 4QY, Northern Ireland, United Kingdom (GB)

Inventor

1

Name:

FITZGERALD, Peter

Address:

Ireland (IE)

2

Name:

LAMONT, John

Address:

Ireland (IE)

3

Name:

WILLIAMSON, Kate E.

Address:

Ireland (IE)

4

Name:

REID, Cherith N.

Address:

Ireland (IE)

5

Name:

RUDDOCK, Mark W.

Address:

Ireland (IE)

Priority

Priority Number:

201501597

Priority Date:

30/01/2015

Priority Country:

United Kingdom (GB)

Classification

IPC classification:

C07K 16/00; G01N 33/574; G01N 33/68;

Publication

European Patent Bulletin

Issue number:

202013

Publication date:

25/03/2020

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages